NMPA Approval

Recombinant Coagulation Factor VIII for Injection

Approval Number

国药准字SJ20210022

Registration Date

August 5, 2021

Drug Information

Generic Name

注射用重组人凝血因子Ⅷ

Trade Name

绿茵芷

Dosage Form

注射剂

Strength

1000 IU/瓶

Drug Type

生物制品

Registration Date

August 5, 2021

Expiry Date

August 4, 2026

Company Address

586, Gwahaksaneop 2-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea

Company Address

586, Gwahaksaneop 2-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea

Empowering clinical research with data-driven insights and AI-powered tools.

注射用重组人凝血因子Ⅷ - NMPA 批准文号 | MedPath